Back to MRKR
Aisling Capital Management LP → MRKR
Aisling Capital Management LP MRKR Position History
Marker Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$348K
Q3 2026
Peak value
$485K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $485K |
| Q1 2026 | $423K |
| Q2 2026 | $478K |
| Q3 2026 | $348K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $348K | 325.4K | — | — |
| Q2 2026 | $478K | 325.4K | — | — |
| Q1 2026 | $423K | 325.4K | — | — |
| Q4 2025 | $485K | 325.4K | — | — |
Other funds holding MRKR
Other Aisling Capital Management LP positions
BBIO
$389.3MBridgeBio Pharma Inc. (BBIO)
BBIO
$378MBridgeBio Pharma Inc. (BBIO)
BBIO
$341.8MBRIDGEBIO PHARMA INC
BBIO
$203.3MBRIDGEBIO PHARMA INC
MNST
$37.6MMONTE ROSA THERAPEUTICS INC
SNDX
$30.8MSyndax Pharmaceuticals, Inc. (SNDX)
SNDX
$28.8MSYNDAX PHARMACEUTICALS INC
SNDX
$27.7MSyndax Pharmaceuticals, Inc. (SNDX)